Tiziana Life Sciences (TLSA) Receivables - Other (2017 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Receivables - Other of $4.0 million for Q4 2025, up 10.45% year-over-year from $3.6 million in Q4 2024, and down 18.29% quarter-over-quarter from $4.9 million in Q2 2025.
Tiziana Life Sciences (TLSA) Receivables - Other (2017 - 2025) Analysis & Trends
Tiziana Life Sciences' Receivables - Other history runs 9 years deep, the most recent figure standing at $4.0 million for Q4 2025.
- In Q4 2025, Receivables - Other rose 10.45% year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (up 10.45% YoY), while the FY2025 annual figure was $4.0 million, up 10.45% from the prior year.
- Receivables - Other for Q4 2025 stood at $4.0 million, down from $4.9 million in the prior quarter.
- The five-year high for Receivables - Other was $4.9 million in Q2 2025, with the low at $456000.0 in Q4 2021.
- The 5-year median for Receivables - Other is $3.6 million (2023), against an average of $2.9 million.
- The sharpest annual moves came in 2022 and 2024: Receivables - Other jumped 896.93% in 2022, then dropped 21.85% in 2024.
- Tiziana Life Sciences' Receivables - Other stood at $456000.0 in 2021, then surged by 896.93% to $4.5 million in 2022, then declined by 11.66% to $4.0 million in 2023, then decreased by 10.18% to $3.6 million in 2024, then increased by 10.45% to $4.0 million in 2025.
- Business Quant data shows TLSA's Receivables - Other at $4.0 million in Q4 2025, $4.9 million in Q2 2025, and $3.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.98 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Jun 30, 2025 | 4.88 Mn |
| Jun 30, 2025 | 4.88 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Jun 30, 2024 | 2.85 Mn |
| Jun 30, 2024 | 2.85 Mn |
| Dec 31, 2023 | 4.02 Mn |
| Dec 31, 2023 | 4.02 Mn |
| Jun 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 3.65 Mn |
| Dec 31, 2022 | 4.55 Mn |
| Dec 31, 2022 | 4.55 Mn |
| Jun 30, 2022 | 608,000.00 |
| Jun 30, 2022 | 608,000.00 |
| Dec 31, 2021 | 456,000.00 |
| Dec 31, 2021 | 456,000.00 |
| Jun 30, 2021 | 465,000.00 |
| Jun 30, 2021 | 465,000.00 |